Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AIDOT is a South Korean medical artificial intelligence company specializing in diagnostic solutions for oncology and neurology. The company's flagship product, Cerviray AI, provides an automated cervical cancer screening system using computer vision to analyze colposcopy images. AIDOT also develops AI-driven tools for stroke screening and gastric cancer detection, aiming to improve diagnostic accuracy and accessibility in global markets. Their technology integrates cloud-based analysis with portable medical devices to support healthcare providers in low-resource settings. The company has secured various international certifications, including CE marking, to facilitate its expansion into Southeast Asia, Latin America, and the Middle East.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AIDOT.